Variations of menstruation which may be indicative of disease.
The periodic shedding of the ENDOMETRIUM and associated menstrual bleeding in the MENSTRUAL CYCLE of humans and primates. Menstruation is due to the decline in circulating PROGESTERONE, and occurs at the late LUTEAL PHASE when LUTEOLYSIS of the CORPUS LUTEUM takes place.
The period from onset of one menstrual bleeding (MENSTRUATION) to the next in an ovulating woman or female primate. The menstrual cycle is regulated by endocrine interactions of the HYPOTHALAMUS; the PITUITARY GLAND; the ovaries; and the genital tract. The menstrual cycle is divided by OVULATION into two phases. Based on the endocrine status of the OVARY, there is a FOLLICULAR PHASE and a LUTEAL PHASE. Based on the response in the ENDOMETRIUM, the menstrual cycle is divided into a proliferative and a secretory phase.
Personal care items used during MENSTRUATION.
Painful menstruation.
The mucous membrane lining of the uterine cavity that is hormonally responsive during the MENSTRUAL CYCLE and PREGNANCY. The endometrium undergoes cyclic changes that characterize MENSTRUATION. After successful FERTILIZATION, it serves to sustain the developing embryo.
Absence of menstruation.
Chemical compounds that induce menstruation either through direct action on the reproductive organs or through indirect action by relieving another condition of which amenorrhea is a secondary result. (From Dorland, 27th ed)
Excessive uterine bleeding during MENSTRUATION.
A condition in which functional endometrial tissue is present outside the UTERUS. It is often confined to the PELVIS involving the OVARY, the ligaments, cul-de-sac, and the uterovesical peritoneum.
A combination of distressing physical, psychologic, or behavioral changes that occur during the luteal phase of the menstrual cycle. Symptoms of PMS are diverse (such as pain, water-retention, anxiety, cravings, and depression) and they diminish markedly 2 or 3 days after the initiation of menses.
The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS.
The first MENSTRUAL CYCLE marked by the initiation of MENSTRUATION.
A synthetic progestational hormone used often in mixtures with estrogens as an oral contraceptive.
The period in the MENSTRUAL CYCLE that follows OVULATION, characterized by the development of CORPUS LUTEUM, increase in PROGESTERONE production by the OVARY and secretion by the glandular epithelium of the ENDOMETRIUM. The luteal phase begins with ovulation and ends with the onset of MENSTRUATION.
Abnormally infrequent menstruation.
The hollow thick-walled muscular organ in the female PELVIS. It consists of the fundus (the body) which is the site of EMBRYO IMPLANTATION and FETAL DEVELOPMENT. Beyond the isthmus at the perineal end of fundus, is CERVIX UTERI (the neck) opening into VAGINA. Beyond the isthmi at the upper abdominal end of fundus, are the FALLOPIAN TUBES.
A synthetic progestational hormone with no androgenic or estrogenic properties. Unlike many other progestational compounds, dydrogesterone produces no increase in temperature and does not inhibit OVULATION.
Bleeding from blood vessels in the UTERUS, sometimes manifested as vaginal bleeding.
Benzenesulfonate derivative used as a systemic hemostatic.
The period of the MENSTRUAL CYCLE representing follicular growth, increase in ovarian estrogen (ESTROGENS) production, and epithelial proliferation of the ENDOMETRIUM. Follicular phase begins with the onset of MENSTRUATION and ends with OVULATION.
A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in conjunction with an opioid analgesic such as FENTANYL to maintain the patient in a calm state of neuroleptanalgesia with indifference to surroundings but still able to cooperate with the surgeon. It is also used as a premedicant, as an antiemetic, and for the control of agitation in acute psychoses. (From Martindale, The Extra Pharmacopoeia, 29th ed, p593)
Accumulations of blood in the PERITONEAL CAVITY due to internal HEMORRHAGE.
The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH.
Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both.
The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids.
Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading.
A synthetic progestational hormone with actions similar to those of PROGESTERONE and about twice as potent as its racemic or (+-)-isomer (NORGESTREL). It is used for contraception, control of menstrual disorders, and treatment of endometriosis.
Blocking the process leading to OVULATION. Various factors are known to inhibit ovulation, such as neuroendocrine, psychological, and pharmacological agents.
Diminished or absent ability of a female to achieve conception.
Conditions characterized by disturbances of usual sleep patterns or behaviors. Sleep disorders may be divided into three major categories: DYSSOMNIAS (i.e. disorders characterized by insomnia or hypersomnia), PARASOMNIAS (abnormal sleep behaviors), and sleep disorders secondary to medical or psychiatric disorders. (From Thorpy, Sleep Disorders Medicine, 1994, p187)
Diseases of animals within the order PRIMATES. This term includes diseases of Haplorhini and Strepsirhini.
The hormone-responsive glandular layer of ENDOMETRIUM that sloughs off at each menstrual flow (decidua menstrualis) or at the termination of pregnancy. During pregnancy, the thickest part of the decidua forms the maternal portion of the PLACENTA, thus named decidua placentalis. The thin portion of the decidua covering the rest of the embryo is the decidua capsularis.
Pathological processes involving the PERITONEUM.
The discharge of an OVUM from a rupturing follicle in the OVARY.
Contraceptive devices placed high in the uterine fundus.
Suspension or cessation of OVULATION in animals or humans with follicle-containing ovaries (OVARIAN FOLLICLE). Depending on the etiology, OVULATION may be induced with appropriate therapy.
The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE.
The genital canal in the female, extending from the UTERUS to the VULVA. (Stedman, 25th ed)
A major gonadotropin secreted by the human adenohypophysis (PITUITARY GLAND, ANTERIOR). Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and the LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. The alpha subunit is common in the three human pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity.
A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity.
Connective tissue cells of an organ found in the loose connective tissue. These are most often associated with the uterine mucosa and the ovary as well as the hematopoietic system and elsewhere.
A family of zinc-dependent metalloendopeptidases that is involved in the degradation of EXTRACELLULAR MATRIX components.
The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.
A synthetic progestin that is derived from 17-hydroxyprogesterone. It is a long-acting contraceptive that is effective both orally or by intramuscular injection and has also been used to treat breast and endometrial neoplasms.
Steroid hormones produced by the GONADS. They stimulate reproductive organs, germ cell maturation, and the secondary sex characteristics in the males and the females. The major sex steroid hormones include ESTRADIOL; PROGESTERONE; and TESTOSTERONE.
Elements of limited time intervals, contributing to particular results or situations.
Decrease in existing BODY WEIGHT.
Works containing information articles on subjects in every field of knowledge, usually arranged in alphabetical order, or a similar work limited to a special field or subject. (From The ALA Glossary of Library and Information Science, 1983)
A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
Increase in BODY WEIGHT over existing weight.
An indicator of body density as determined by the relationship of BODY WEIGHT to BODY HEIGHT. BMI=weight (kg)/height squared (m2). BMI correlates with body fat (ADIPOSE TISSUE). Their relationship varies with age and gender. For adults, BMI falls into these categories: below 18.5 (underweight); 18.5-24.9 (normal); 25.0-29.9 (overweight); 30.0 and above (obese). (National Center for Health Statistics, Centers for Disease Control and Prevention)
A heterogeneous group of disorders, some hereditary, others acquired, characterized by abnormal structure or function of one or more of the elements of connective tissue, i.e., collagen, elastin, or the mucopolysaccharides.

Hip fractures among infertile women. (1/304)

A retrospective cohort study was conducted in a population-based inception cohort of 1,157 Olmsted County, Minnesota, women with infertility (failure to conceive after 1 year despite intercourse without contraception) that was first diagnosed at the Mayo Clinic (Rochester, Minnesota) between 1935 and 1964. In this relatively young cohort, 31 hip fractures were observed during 35,849 person-years of follow-up; 36.5 had been expected (standardized incidence ratio = 0.85, 95% confidence interval 0.58-1.20). Standardized incidence ratios did not differ by type or cause of infertility. The data suggested that women with consistently irregular menses may have a greater risk of hip fracture. This finding should be confirmed by additional studies with longer follow-up periods and with assessment of other fracture outcomes.  (+info)

Work stress and menstrual patterns among American and Italian nurses. (2/304)

OBJECTIVES: This study assessed whether job stress alters menstrual patterns among nurses working in 2 different settings: a tertiary care hospital in New York (99 nurses) and a university hospital in Rome (25 nurses). METHODS: Data on menstrual patterns were collected by a daily diary in which the nurses recorded their basal body temperature (BBT) and their menstrual bleeding status for a 3-month period. The BBT curves were used to classify cycles as biphasic or monophasic, and as adequate or inadequate with respect to the luteal phase. Job stress was evaluated by both objective (environmental and work characteristics) and subjective (perceived stress) criteria. RESULTS: The American nurses, especially those assigned to high stress units, had an increased risk for long and monophasic cycles [relative risk (RR) 4.3, 95% confidence interval (95% CI) 1.1-16.2 and RR 5.5, 95% CI 1.2-25.5, respectively]. Among those who perceived their stress at work to be high or reported strenuous work activity, the risk for longer cycles was also raised (RR 2.3, 95% CI 0.6-8.0 and RR 1.6, 95% CI 0.7-4.2, respectively). Luteal phase inadequacy followed the same pattern. Similar trends were observed in the Italian data. In addition, the rotating shiftwork pattern prevalent in the Italian group was possibly associated with higher rates of short cycles and inadequate luteal phases when compared with those of nurses working fixed shifts either day or night. CONCLUSIONS: Menstrual function may be affected by stressful work conditions.  (+info)

Signalling possible drug-drug interactions in a spontaneous reporting system: delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazole. (3/304)

AIMS: In spontaneous adverse drug reaction reporting systems, there is a growing need for methods facilitating the automated detection of signals concerning possible adverse drug reactions. In addition, special attention is needed for the detection of adverse drug reactions resulting from possible drug-drug interactions. We describe a method for detecting possible drug-drug interactions using logistic regression analysis to calculate ADR reporting odds ratios. METHODS: To illustrate this method, we analysed the adverse drug reaction 'delayed withdrawal bleeding' resulting from a possible interaction between itraconazole and oral contraceptives in reports received by the Netherlands Pharmacovigilance Foundation LAREB between 1991 and 1998. RESULTS: In total 5,503 reports were included in the study. The odds ratio, adjusted for year of reporting, age and source of the reports, for a delayed withdrawal bleeding in women who used both drugs concomitantly compared with women who used neither oral contraceptives, nor itraconazole, was 85 (95% CI: 32-230). CONCLUSIONS: Since spontaneous reporting systems can only generate signals concerning possible relationships, this association needs to be analysed by other methods in more detail in order to determine the real strength of the relationship. This approach might be a promising tool for the development of procedures for automated detection of possible drug-drug interactions in spontaneous reporting systems.  (+info)

Effective treatment of subfertility: introducing the Cochrane Menstrual Disorders and Subfertility Group. (4/304)

The last two decades have seen a rapid explosion in research surrounding subfertility treatments. This ever-increasing volume of research has made it a difficult task for health professionals involved in the management of the subfertility to be able to assimilate the information easily. There is an urgent need for the findings from research to be synthesized into simple easy to read reviews that are both of a high quality and are based on the best evidence available. The Menstrual Disorders and Subfertility Group of the Cochrane Collaboration is attempting to address these issues by collecting a register of all the randomized controlled trials in the field of reproductive medicine and preparing systematic reviews on topics that will be of interest to healthcare workers and consumers. Readers are invited to participate in this process by identifying published and unpublished data and by helping in the process of preparing protocols and systematic reviews for inclusion in the Cochrane Library.  (+info)

The oral contraceptive pill: a revolution for sportswomen? (5/304)

OBJECTIVES: To determine the effects of the oral contraceptive pill (OCP) on skeletal health, soft tissue injury, and performance in female athletes. METHODS: A literature review was performed using literature retrieval methods to locate relevant studies. RESULTS: Most female athletes primarily choose to use the OCP for contraceptive purposes, but cycle manipulation and control of premenstrual symptoms are secondary advantages of its use. The effect of the OCP on bone density in normally menstruating women is unclear, with some studies reporting no effect, others a positive effect, and some even a negative effect. The OCP is often prescribed for the treatment of menstrual disturbances in female athletes, and improvements in bone density may result. Whether the OCP influences the risk of stress fracture and soft tissue injuries is not clear from research to date. Effects of the OCP on performance are particularly relevant for elite sportswomen. Although a reduction in Vo2MAX has been reported in some studies, this may not necessarily translate to impaired performance in the field. Moreover, some studies claim that the OCP may well enhance performance by reducing premenstrual symptoms and menstrual blood loss. A fear of weight gain with the use of the OCP is not well founded, as population studies report no effect on weight, particularly with the lower dose pills currently available. CONCLUSIONS: Overall, the advantages of the pill for sportswomen would appear to outweigh any potential disadvantages. Nevertheless, there is individual variation in response to the OCP and these should be taken into account and monitored in the clinical situation. Women should be counselled as to the range of potential benefits and disadvantages in order to make an informed decision based on individual circumstances.  (+info)

Vegetarianism and menstrual cycle disturbances: is there an association? (6/304)

The question of whether menstrual disturbances are more common in vegetarian than in nonvegetarian women is complex. Disturbances of the cycle may be clinical (ie, amenorrhea or oligomenorrhea) or subclinical (i.e., normal-length cycles with anovulation or a short or defective luteal phase). Detection of the latter requires that the menstrual cycle be monitored, but may help prevent recruitment bias in studies comparing vegetarians with nonvegetarians because vegetarians with menstrual disturbances may be more likely to volunteer for a study on menstrual disturbances and vegetarianism. Three general mechanisms that could contribute to menstrual disturbances that may differ between vegetarians and nonvegetarians include energy imbalances associated with body-weight disturbances or exercise, psychosocial and cognitive factors, and dietary components. Evidence for each of these mechanisms is reviewed and studies comparing menstrual function between vegetarians and nonvegetarians are described in this article. Although results from several cross-sectional studies suggest that clinical menstrual disturbances may be more common in vegetarians, a prospective study that controlled for many potential confounders found that subclinical disturbances were less common in weight-stable, healthy vegetarian women. Because the sample studied may not be representative of all vegetarian women, however, these results cannot be generalized. Population studies are needed to draw definitive conclusions.  (+info)

Abnormal uterine bleeding. (7/304)

The most probable etiology of abnormal uterine bleeding relates to the patient's reproductive age, as does the likelihood of serious endometrial pathology. The specific diagnostic approach depends on whether the patient is premenopausal, perimenopausal or postmenopausal. In premenopausal women with normal findings on physical examination, the most likely diagnosis is dysfunctional uterine bleeding (DUB) secondary to anovulation, and the diagnostic investigation is targeted at identifying the etiology of anovulation. In perimenopausal patients, endometrial biopsy and other methods of detecting endometrial hyperplasia or carcinoma must be considered early in the investigation. Uterine pathology, particularly endometrial carcinoma, is common in postmenopausal women with abnormal uterine bleeding. Thus, in this age group, endometrial biopsy or transvaginal ultrasonography is included in the initial investigation. Premenopausal women with DUB may respond to oral contraceptives, cyclic medroxyprogesterone therapy or cyclic clomiphene. Perimenopausal women may also be treated with low-dose oral contraceptives or medroxyprogesterone. Erratic bleeding during hormone replacement therapy in postmenopausal women with no demonstrable pathology may respond to manipulation of the hormone regimen.  (+info)

Three cases of macroprolactinaemia. (8/304)

A woman with hirsutism but otherwise symptom-free was found to have a raised serum prolactin and a pituitary microadenoma. The hyperprolactinaemia persisted despite bromocriptine therapy and subsequent pituitary surgery, which yielded a non-functioning adenoma. After a further 15 years with persistent hyperprolactinaemia but no symptoms, macroprolactinaemia was diagnosed. Such cases might account for part of the failure rate of pituitary microsurgery for prolactinoma. Testing for macroprolactinaemia is advisable in a woman with hyperprolactinaemia, especially if her ovulatory cycle is normal. Two other cases are reported in which macroprolactinaemia was associated with menstrual disturbances and other hormonal effects: in these, treatment with dopamine agonists suppressed the hyperprolactinaemia and restored normal menstrual cycles.  (+info)

Menstruation disturbances, also known as menstrual disorders, refer to any irregularities or abnormalities in a woman's menstrual cycle. These disturbances can manifest in various ways, including:

1. Amenorrhea: The absence of menstrual periods for three consecutive cycles or more in women of reproductive age.
2. Oligomenorrhea: Infrequent or light menstrual periods that occur at intervals greater than 35 days.
3. Dysmenorrhea: Painful menstruation, often accompanied by cramping, pelvic pain, and other symptoms that can interfere with daily activities.
4. Menorrhagia: Heavy or prolonged menstrual periods that last longer than seven days or result in excessive blood loss, leading to anemia or other health complications.
5. Polymenorrhea: Abnormally frequent menstrual periods that occur at intervals of 21 days or less.
6. Metrorrhagia: Irregular and unpredictable vaginal bleeding between expected menstrual periods, which can be caused by various factors such as hormonal imbalances, infections, or structural abnormalities.

Menstruation disturbances can have significant impacts on a woman's quality of life, fertility, and overall health. They may result from various underlying conditions, including hormonal imbalances, polycystic ovary syndrome (PCOS), thyroid disorders, uterine fibroids, endometriosis, or sexually transmitted infections. Proper diagnosis and treatment of the underlying cause are essential for managing menstruation disturbances effectively.

Menstruation is the regular, cyclical shedding of the uterine lining (endometrium) in women and female individuals of reproductive age, accompanied by the discharge of blood and other materials from the vagina. It typically occurs every 21 to 35 days and lasts for approximately 2-7 days. This process is a part of the menstrual cycle, which is under the control of hormonal fluctuations involving follicle-stimulating hormone (FSH), luteinizing hormone (LH), estrogen, and progesterone.

The menstrual cycle can be divided into three main phases:

1. Menstruation phase: The beginning of the cycle is marked by the start of menstrual bleeding, which signals the breakdown and shedding of the endometrium due to the absence of pregnancy and low levels of estrogen and progesterone. This phase typically lasts for 2-7 days.

2. Proliferative phase: After menstruation, under the influence of rising estrogen levels, the endometrium starts to thicken and regenerate. The uterine lining becomes rich in blood vessels and glands, preparing for a potential pregnancy. This phase lasts from day 5 until around day 14 of an average 28-day cycle.

3. Secretory phase: Following ovulation (release of an egg from the ovaries), which usually occurs around day 14, increased levels of progesterone cause further thickening and maturation of the endometrium. The glands in the lining produce nutrients to support a fertilized egg. If pregnancy does not occur, both estrogen and progesterone levels will drop, leading to menstruation and the start of a new cycle.

Understanding menstruation is essential for monitoring reproductive health, identifying potential issues such as irregular periods or menstrual disorders, and planning family planning strategies.

The menstrual cycle is a series of natural changes that occur in the female reproductive system over an approximate 28-day interval, marking the body's preparation for potential pregnancy. It involves the interplay of hormones that regulate the growth and disintegration of the uterine lining (endometrium) and the release of an egg (ovulation) from the ovaries.

The menstrual cycle can be divided into three main phases:

1. Menstrual phase: The cycle begins with the onset of menstruation, where the thickened uterine lining is shed through the vagina, lasting typically for 3-7 days. This shedding occurs due to a decrease in estrogen and progesterone levels, which are hormones essential for maintaining the endometrium during the previous cycle.

2. Follicular phase: After menstruation, the follicular phase commences with the pituitary gland releasing follicle-stimulating hormone (FSH). FSH stimulates the growth of several ovarian follicles, each containing an immature egg. One dominant follicle usually becomes selected to mature and release an egg during ovulation. Estrogen levels rise as the dominant follicle grows, causing the endometrium to thicken in preparation for a potential pregnancy.

3. Luteal phase: Following ovulation, the ruptured follicle transforms into the corpus luteum, which produces progesterone and estrogen to further support the endometrial thickening. If fertilization does not occur within approximately 24 hours after ovulation, the corpus luteum will degenerate, leading to a decline in hormone levels. This drop triggers the onset of menstruation, initiating a new menstrual cycle.

Understanding the menstrual cycle is crucial for monitoring reproductive health and planning or preventing pregnancies. Variations in cycle length and symptoms are common among women, but persistent irregularities may indicate underlying medical conditions requiring further evaluation by a healthcare professional.

Menstrual hygiene products are items used by menstruating individuals to absorb or collect blood and maintain cleanliness and comfort during menstruation. These products typically include sanitary napkins, tampons, menstrual cups, and reusable cloth pads. They are designed to be safe, comfortable, and effective in managing menstrual flow and preventing leakage, while also being convenient and discreet to use. It is essential to maintain proper menstrual hygiene to prevent discomfort, skin irritation, and infection during menstruation.

Dysmenorrhea is a medical term that refers to painful menstrual cramps and discomfort during menstruation. It's one of the most common gynecological complaints among women of reproductive age. There are two types of dysmenorrhea: primary and secondary.

1. Primary Dysmenorrhea: This type is more common and occurs in women who have had normal, pelvic anatomy. The pain is caused by strong contractions of the uterus due to the production of prostaglandins (hormone-like substances that are involved in inflammation and pain). Primary dysmenorrhea usually starts soon after menarche (the beginning of menstruation) and tends to improve with age, particularly after childbirth.
2. Secondary Dysmenorrhea: This type is less common and occurs due to an underlying medical condition affecting the reproductive organs, such as endometriosis, uterine fibroids, pelvic inflammatory disease (PID), or adenomyosis. The pain associated with secondary dysmenorrhea tends to worsen over time and may be accompanied by other symptoms like irregular menstrual bleeding, pain during intercourse, or chronic pelvic pain.

Treatment for dysmenorrhea depends on the type and underlying cause. For primary dysmenorrhea, nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen can help alleviate pain by reducing prostaglandin production. Hormonal birth control methods like oral contraceptives and intrauterine devices (IUDs) may also be prescribed to reduce menstrual pain. For secondary dysmenorrhea, treatment typically involves addressing the underlying medical condition causing the pain.

The endometrium is the innermost layer of the uterus, which lines the uterine cavity and has a critical role in the menstrual cycle and pregnancy. It is composed of glands and blood vessels that undergo cyclic changes under the influence of hormones, primarily estrogen and progesterone. During the menstrual cycle, the endometrium thickens in preparation for a potential pregnancy. If fertilization does not occur, it will break down and be shed, resulting in menstruation. In contrast, if implantation takes place, the endometrium provides essential nutrients to support the developing embryo and placenta throughout pregnancy.

Amenorrhea is a medical condition characterized by the absence or cessation of menstrual periods in women of reproductive age. It can be categorized as primary amenorrhea, when a woman who has not yet had her first period at the expected age (usually around 16 years old), or secondary amenorrhea, when a woman who has previously had regular periods stops getting them for six months or more.

There are various causes of amenorrhea, including hormonal imbalances, pregnancy, breastfeeding, menopause, extreme weight loss or gain, eating disorders, intense exercise, stress, chronic illness, tumors, and certain medications or medical treatments. In some cases, amenorrhea may indicate an underlying medical condition that requires further evaluation and treatment.

Amenorrhea can have significant impacts on a woman's health and quality of life, including infertility, bone loss, and emotional distress. Therefore, it is essential to consult with a healthcare provider if you experience amenorrhea or missed periods to determine the underlying cause and develop an appropriate treatment plan.

Menstruation-inducing agents, also known as menstrual induction agents or abortifacients, are medications or substances that stimulate or induce menstruation and can potentially lead to the termination of an early pregnancy. These agents work by causing the uterus to contract and expel its lining (endometrium), which is shed during menstruation.

Common menstruation-inducing agents include:

1. Hormonal medications: Combination oral contraceptives, containing both estrogen and progestin, can be used to induce menstruation by causing the uterus to shed its lining after a planned break from taking the medication. This is often used in birth control methods like the "birth control pill pack."
2. Prostaglandins: These are naturally occurring hormone-like substances that can cause the uterus to contract. Synthetic prostaglandin analogs, such as misoprostol (Cytotec), can be used to induce menstruation or early pregnancy termination.
3. Mifepristone: This is a synthetic steroid hormone that blocks progesterone receptors in the body. When used in combination with prostaglandins, it can cause the uterus to contract and expel its lining, leading to an abortion or inducing menstruation.

It's important to note that using menstruation-inducing agents without medical supervision or for purposes other than their intended use may pose health risks and should be avoided. Always consult a healthcare professional before using any medication for this purpose.

Menorrhagia is a medical term used to describe abnormally heavy or prolonged menstrual periods. It's often characterized by the loss of an excessive amount of menstrual blood (usually more than 80 ml) and can last longer than normal, typically over seven days. This condition can have significant impacts on a woman's quality of life, causing fatigue, distress, and restrictions in daily activities due to the need for frequent pad or tampon changes.

The causes of menorrhagia are varied and can include hormonal imbalances, uterine fibroids or polyps, endometrial hyperplasia, pelvic inflammatory disease, pregnancy complications, certain medications, and underlying medical conditions such as coagulopathies or thyroid disorders. In some cases, the cause may remain undetermined even after a thorough evaluation.

Treatment options for menorrhagia depend on the underlying cause and range from medication management with hormonal therapies, nonsteroidal anti-inflammatory drugs (NSAIDs), or tranexamic acid to procedural interventions like endometrial ablation, hysteroscopic resection of polyps or fibroids, or ultimately hysterectomy in severe cases. It is essential for individuals experiencing menorrhagia to consult with their healthcare provider to determine the best course of action based on their specific situation and medical history.

Endometriosis is a medical condition in which tissue similar to the lining of the uterus (endometrium) grows outside the uterine cavity, most commonly on the ovaries, fallopian tubes, and the pelvic peritoneum. This misplaced endometrial tissue continues to act as it would inside the uterus, thickening, breaking down, and bleeding with each menstrual cycle. However, because it is outside the uterus, this blood and tissue have no way to exit the body and can lead to inflammation, scarring, and the formation of adhesions (tissue bands that bind organs together).

The symptoms of endometriosis may include pelvic pain, heavy menstrual periods, painful intercourse, and infertility. The exact cause of endometriosis is not known, but several theories have been proposed, including retrograde menstruation (the backflow of menstrual blood through the fallopian tubes into the pelvic cavity), genetic factors, and immune system dysfunction.

Endometriosis can be diagnosed through a combination of methods, such as medical history, physical examination, imaging tests like ultrasound or MRI, and laparoscopic surgery with tissue biopsy. Treatment options for endometriosis include pain management, hormonal therapies, and surgical intervention to remove the misplaced endometrial tissue. In severe cases, a hysterectomy (removal of the uterus) may be recommended, but this is typically considered a last resort due to its impact on fertility and quality of life.

Premenstrual Syndrome (PMS) is a complex of symptoms that occur in the latter part of the luteal phase (the second half) of the menstrual cycle, typically starting 5-11 days before the onset of menses, and remitting shortly after the onset of menstruation. The symptoms can be physical, psychological, or behavioral and vary from mild to severe. They include but are not limited to: bloating, breast tenderness, cramps, headaches, mood swings, irritability, depression, anxiety, fatigue, changes in appetite, and difficulty concentrating.

The exact cause of PMS is not known, but it appears to be related to hormonal changes during the menstrual cycle, particularly fluctuations in estrogen and progesterone levels. Some women may be more susceptible to these hormonal shifts due to genetic factors, neurotransmitter imbalances, or other health conditions.

Treatment for PMS often involves a combination of lifestyle changes (such as regular exercise, stress management, and dietary modifications), over-the-counter pain relievers, and, in some cases, hormonal medications or antidepressants. It's important to consult with a healthcare provider for an accurate diagnosis and treatment plan.

Progesterone is a steroid hormone that is primarily produced in the ovaries during the menstrual cycle and in pregnancy. It plays an essential role in preparing the uterus for implantation of a fertilized egg and maintaining the early stages of pregnancy. Progesterone works to thicken the lining of the uterus, creating a nurturing environment for the developing embryo.

During the menstrual cycle, progesterone is produced by the corpus luteum, a temporary structure formed in the ovary after an egg has been released from a follicle during ovulation. If pregnancy does not occur, the levels of progesterone will decrease, leading to the shedding of the uterine lining and menstruation.

In addition to its reproductive functions, progesterone also has various other effects on the body, such as helping to regulate the immune system, supporting bone health, and potentially influencing mood and cognition. Progesterone can be administered medically in the form of oral pills, intramuscular injections, or vaginal suppositories for various purposes, including hormone replacement therapy, contraception, and managing certain gynecological conditions.

Menarche is the first occurrence of menstruation in a female adolescent, indicating the onset of reproductive capability. It usually happens between the ages of 10 and 16, with an average age of around 12-13 years old, but it can vary widely from one individual to another due to various factors such as genetics, nutrition, and overall health.

Achieving menarche is a significant milestone in a girl's life, signaling the transition from childhood to adolescence. It is also an essential indicator of sexual maturation, often used in conjunction with other physical changes to assess pubertal development. However, it does not necessarily mean that a girl is psychologically or emotionally prepared for menstruation and sexual activity; therefore, appropriate education and support are crucial during this period.

Lynestrenol is a synthetic form of progestogen, which is a female sex hormone. It is used in various medications for different purposes, such as treating abnormal menstrual bleeding, endometriosis, and preventing premature labor. Lynestrenol works by mimicking the effects of natural progesterone in the body, helping to regulate the menstrual cycle and reduce inflammation associated with endometriosis. It is important to note that lynestrenol should only be used under the supervision of a healthcare professional, as it can have side effects and interact with other medications.

The luteal phase is the second half of the menstrual cycle, starting from ovulation (release of an egg from the ovaries) and lasting until the start of the next menstruation. This phase typically lasts around 12-14 days in a regular 28-day menstrual cycle. During this phase, the remains of the dominant follicle that released the egg transform into the corpus luteum, which produces progesterone and some estrogen to support the implantation of a fertilized egg and maintain the early stages of pregnancy. If pregnancy does not occur, the corpus luteum degenerates, leading to a drop in hormone levels and the start of a new menstrual cycle.

Oligomenorrhea is a medical term used to describe infrequent menstrual periods, where the cycle length is more than 35 days but less than 68 days. It's considered a menstrual disorder and can affect people of reproductive age. The causes of oligomenorrhea are varied, including hormonal imbalances, polycystic ovary syndrome (PCOS), thyroid disorders, excessive exercise, significant weight loss or gain, and stress. In some cases, it may not cause any other symptoms, but in others, it can be associated with infertility, hirsutism (excessive hair growth), acne, or obesity. Treatment depends on the underlying cause and may include lifestyle modifications, hormonal medications, or surgery in rare cases.

The uterus, also known as the womb, is a hollow, muscular organ located in the female pelvic cavity, between the bladder and the rectum. It has a thick, middle layer called the myometrium, which is composed of smooth muscle tissue, and an inner lining called the endometrium, which provides a nurturing environment for the fertilized egg to develop into a fetus during pregnancy.

The uterus is where the baby grows and develops until it is ready for birth through the cervix, which is the lower, narrow part of the uterus that opens into the vagina. The uterus plays a critical role in the menstrual cycle as well, by shedding its lining each month if pregnancy does not occur.

Dydrogesterone is a synthetic form of the natural hormone progesterone, which is used in various forms of medical therapy. It is primarily used as a hormonal supplement during infertility treatments and to prevent pregnancy loss in women with a history of miscarriage due to progesterone deficiency.

Dydrogesterone works by mimicking the effects of natural progesterone, which helps to prepare the lining of the uterus for implantation of a fertilized egg and supports the early stages of pregnancy. It is also used in the treatment of endometriosis, a condition where tissue similar to the lining of the uterus grows outside of it, causing pain and other symptoms.

Dydrogesterone is available in various forms, including tablets and capsules, and is typically taken orally. The dosage and duration of treatment may vary depending on the specific medical condition being treated and the individual patient's needs. As with any medication, dydrogesterone should only be used under the guidance and supervision of a qualified healthcare provider.

Uterine hemorrhage, also known as uterine bleeding or gynecological bleeding, is an abnormal loss of blood from the uterus. It can occur in various clinical settings such as menstruation (known as menorrhagia), postpartum period (postpartum hemorrhage), or in non-pregnant women (dysfunctional uterine bleeding). The bleeding may be light to heavy, intermittent or continuous, and can be accompanied by symptoms such as pain, dizziness, or fainting. Uterine hemorrhage is a common gynecological problem that can have various underlying causes, including hormonal imbalances, structural abnormalities, coagulopathies, and malignancies. It is important to seek medical attention if experiencing heavy or prolonged uterine bleeding to determine the cause and receive appropriate treatment.

Ethamsylate is a medication that belongs to a class of drugs known as anti-fibrinolytics. It works by helping to prevent the breakdown of blood clots and promoting the healing of damaged blood vessels. Ethamsylate is often used in the treatment of conditions associated with bleeding, such as menorrhagia (heavy menstrual periods) and various types of hemorrhage (severe bleeding).

The chemical name for Ethamsylate is diethylammonium 3,4-dimethoxybenzenesulfonate. It is available in oral tablet form and is typically prescribed to be taken two to three times a day, depending on the severity of the condition being treated. As with any medication, it's important to follow your healthcare provider's instructions carefully when taking Ethamsylate.

While Ethamsylate can be effective in treating certain types of bleeding, it is not without potential side effects. Common side effects may include gastrointestinal symptoms such as nausea, vomiting, and diarrhea. In rare cases, more serious side effects such as allergic reactions, kidney damage, or changes in blood pressure may occur. If you experience any unusual symptoms while taking Ethamsylate, it's important to contact your healthcare provider right away.

The follicular phase is a term used in reproductive endocrinology, which refers to the first part of the menstrual cycle. This phase begins on the first day of menstruation and lasts until ovulation. During this phase, several follicles in the ovaries begin to mature under the influence of follicle-stimulating hormone (FSH) released by the pituitary gland.

Typically, one follicle becomes dominant and continues to mature, while the others regress. The dominant follicle produces increasing amounts of estrogen, which causes the lining of the uterus to thicken in preparation for a possible pregnancy. The follicular phase can vary in length, but on average it lasts about 14 days.

It's important to note that the length and characteristics of the follicular phase can provide valuable information in diagnosing various reproductive disorders, such as polycystic ovary syndrome (PCOS) or thyroid dysfunction.

Droperidol is a butyrophenone neuroleptic medication that is primarily used for its antiemetic (anti-nausea and vomiting) properties. It works by blocking dopamine receptors in the brain, which can help to reduce feelings of nausea and vomiting caused by various factors such as chemotherapy, surgery, or motion sickness.

Droperidol is also known for its sedative and anxiolytic (anxiety-reducing) effects, and has been used in the past as a premedication before surgery to help reduce anxiety and produce sedation. However, due to concerns about rare but serious side effects such as QT prolongation (a heart rhythm disorder), droperidol is now less commonly used for this purpose.

Droperidol is available in injectable form and is typically administered by healthcare professionals in a hospital or clinical setting. It should be used with caution and only under the close supervision of a healthcare provider, as it can cause a range of side effects including dizziness, drowsiness, dry mouth, and restlessness. More serious side effects such as seizures, irregular heartbeat, and neuroleptic malignant syndrome (a rare but potentially life-threatening condition characterized by muscle rigidity, fever, and autonomic instability) have also been reported with droperidol use.

Hemoperitoneum is a medical condition characterized by the presence of blood in the peritoneal cavity, which is the space between the lining of the abdominal wall and the organs within it. This can occur due to various reasons such as trauma, rupture of an abdominal aortic aneurysm, ectopic pregnancy, or other conditions that cause bleeding into the abdomen.

The accumulation of blood in the peritoneal cavity can lead to symptoms such as abdominal pain, tenderness, distension, and hypovolemic shock due to blood loss. Hemoperitoneum is a serious medical condition that requires prompt diagnosis and treatment to prevent further complications.

Pregnancy is a physiological state or condition where a fertilized egg (zygote) successfully implants and grows in the uterus of a woman, leading to the development of an embryo and finally a fetus. This process typically spans approximately 40 weeks, divided into three trimesters, and culminates in childbirth. Throughout this period, numerous hormonal and physical changes occur to support the growing offspring, including uterine enlargement, breast development, and various maternal adaptations to ensure the fetus's optimal growth and well-being.

Oral contraceptives, also known as "birth control pills," are medications taken by mouth to prevent pregnancy. They contain synthetic hormones that mimic the effects of natural hormones estrogen and progesterone in a woman's body, thereby preventing ovulation, fertilization, or implantation of a fertilized egg in the uterus.

There are two main types of oral contraceptives: combined pills, which contain both estrogen and progestin, and mini-pills, which contain only progestin. Combined pills work by preventing ovulation, thickening cervical mucus to make it harder for sperm to reach the egg, and thinning the lining of the uterus to make it less likely for a fertilized egg to implant. Mini-pills work mainly by thickening cervical mucus and changing the lining of the uterus.

Oral contraceptives are highly effective when used correctly, but they do not protect against sexually transmitted infections (STIs). It is important to use them consistently and as directed by a healthcare provider. Side effects may include nausea, breast tenderness, headaches, mood changes, and irregular menstrual bleeding. In rare cases, oral contraceptives may increase the risk of serious health problems such as blood clots, stroke, or liver tumors. However, for most women, the benefits of using oral contraceptives outweigh the risks.

Estradiol is a type of estrogen, which is a female sex hormone. It is the most potent and dominant form of estrogen in humans. Estradiol plays a crucial role in the development and maintenance of secondary sexual characteristics in women, such as breast development and regulation of the menstrual cycle. It also helps maintain bone density, protect the lining of the uterus, and is involved in cognition and mood regulation.

Estradiol is produced primarily by the ovaries, but it can also be synthesized in smaller amounts by the adrenal glands and fat cells. In men, estradiol is produced from testosterone through a process called aromatization. Abnormal levels of estradiol can contribute to various health issues, such as hormonal imbalances, infertility, osteoporosis, and certain types of cancer.

Contraceptive agents, female, are medications or devices specifically designed to prevent pregnancy in women. They work by interfering with the normal process of ovulation, fertilization, or implantation of a fertilized egg in the uterus. Some common examples of female contraceptive agents include:

1. Hormonal methods: These include combined oral contraceptives (COCs), progestin-only pills, patches, vaginal rings, and hormonal implants. They contain synthetic forms of the female hormones estrogen and/or progesterone, which work by preventing ovulation, thickening cervical mucus to make it harder for sperm to reach the egg, or thinning the lining of the uterus to prevent implantation of a fertilized egg.
2. Intrauterine devices (IUDs): These are small, T-shaped devices made of plastic or copper that are inserted into the uterus by a healthcare provider. They release hormones or copper ions that interfere with sperm movement and prevent fertilization or implantation.
3. Barrier methods: These include condoms, diaphragms, cervical caps, and sponges. They work by physically preventing sperm from reaching the egg.
4. Emergency contraception: This includes medications such as Plan B or Ella, which can be taken up to 5 days after unprotected sex to prevent pregnancy. They work by delaying ovulation or preventing fertilization of the egg.
5. Fertility awareness-based methods (FABMs): These involve tracking a woman's menstrual cycle and avoiding sexual intercourse during her fertile window. Some FABMs also involve using barrier methods during this time.

It is important to note that different contraceptive agents have varying levels of effectiveness, side effects, and risks. Women should consult with their healthcare provider to determine the best method for their individual needs and circumstances.

Levonorgestrel is a synthetic form of the natural hormone progesterone, which is used in various forms of birth control and emergency contraceptives. It works by preventing ovulation (the release of an egg from the ovaries), thickening cervical mucus to make it harder for sperm to reach the egg, and thinning the lining of the uterus to make it less likely for a fertilized egg to implant.

Medically, Levonorgestrel is classified as a progestin and is available in various forms, including oral tablets, intrauterine devices (IUDs), and emergency contraceptive pills. It may also be used to treat endometriosis, irregular menstrual cycles, and heavy menstrual bleeding.

It's important to note that while Levonorgestrel is a highly effective form of birth control when used correctly, it does not protect against sexually transmitted infections (STIs). Therefore, condoms should still be used during sexual activity if there is any risk of STI transmission.

Ovulation inhibition is a term used in reproductive medicine to describe the prevention or delay of ovulation, which is the release of a mature egg from the ovaries during the menstrual cycle. This can be achieved through various means, such as hormonal contraceptives (birth control pills, patches, rings), injectable hormones, or intrauterine devices (IUDs) that release hormones.

Hormonal contraceptives typically contain synthetic versions of the hormones estrogen and progestin, which work together to inhibit the natural hormonal signals that trigger ovulation. By suppressing the surge in luteinizing hormone (LH) and follicle-stimulating hormone (FSH), these methods prevent the development and release of a mature egg from the ovaries.

In addition to preventing ovulation, hormonal contraceptives can also thicken cervical mucus, making it more difficult for sperm to reach the egg, and thin the lining of the uterus, reducing the likelihood of implantation in case fertilization does occur. It is important to note that while ovulation inhibition is a reliable method of birth control, it may not provide protection against sexually transmitted infections (STIs).

Female infertility is a condition characterized by the inability to conceive after 12 months or more of regular, unprotected sexual intercourse or the inability to carry a pregnancy to a live birth. The causes of female infertility can be multifactorial and may include issues with ovulation, damage to the fallopian tubes or uterus, endometriosis, hormonal imbalances, age-related factors, and other medical conditions.

Some common causes of female infertility include:

1. Ovulation disorders: Conditions such as polycystic ovary syndrome (PCOS), thyroid disorders, premature ovarian failure, and hyperprolactinemia can affect ovulation and lead to infertility.
2. Damage to the fallopian tubes: Pelvic inflammatory disease, endometriosis, or previous surgeries can cause scarring and blockages in the fallopian tubes, preventing the egg and sperm from meeting.
3. Uterine abnormalities: Structural issues with the uterus, such as fibroids, polyps, or congenital defects, can interfere with implantation and pregnancy.
4. Age-related factors: As women age, their fertility declines due to a decrease in the number and quality of eggs.
5. Other medical conditions: Certain medical conditions, such as diabetes, celiac disease, and autoimmune disorders, can contribute to infertility.

In some cases, female infertility can be treated with medications, surgery, or assisted reproductive technologies (ART) like in vitro fertilization (IVF). A thorough evaluation by a healthcare professional is necessary to determine the underlying cause and develop an appropriate treatment plan.

Sleep disorders are a group of conditions that affect the ability to sleep well on a regular basis. They can include problems with falling asleep, staying asleep, or waking up too early in the morning. These disorders can be caused by various factors such as stress, anxiety, depression, medical conditions, or substance abuse.

The American Academy of Sleep Medicine (AASM) recognizes over 80 distinct sleep disorders, which are categorized into the following major groups:

1. Insomnia - difficulty falling asleep or staying asleep.
2. Sleep-related breathing disorders - abnormal breathing during sleep such as obstructive sleep apnea.
3. Central disorders of hypersomnolence - excessive daytime sleepiness, including narcolepsy.
4. Circadian rhythm sleep-wake disorders - disruption of the internal body clock that regulates the sleep-wake cycle.
5. Parasomnias - abnormal behaviors during sleep such as sleepwalking or night terrors.
6. Sleep-related movement disorders - repetitive movements during sleep such as restless legs syndrome.
7. Isolated symptoms and normal variants - brief and occasional symptoms that do not warrant a specific diagnosis.

Sleep disorders can have significant impacts on an individual's quality of life, productivity, and overall health. If you suspect that you may have a sleep disorder, it is recommended to consult with a healthcare professional or a sleep specialist for proper evaluation and treatment.

Primatology is the study of primates, which includes humans and non-human primates such as monkeys, apes, and lemurs. Primate diseases refer to the range of infectious and non-infectious health conditions that affect these animals. These diseases can be caused by various factors including bacteria, viruses, parasites, fungi, genetics, environmental conditions, and human activities such as habitat destruction, hunting, and keeping primates as pets.

Examples of primate diseases include:

1. Retroviral infections: Primates are susceptible to retroviruses, including simian immunodeficiency virus (SIV) which is the precursor to human immunodeficiency virus (HIV).
2. Herpesviruses: Many primate species are infected with herpesviruses that can cause a range of diseases from mild skin infections to severe neurological disorders.
3. Tuberculosis: Primates can contract tuberculosis, which is caused by the bacterium Mycobacterium tuberculosis and can affect multiple organs.
4. Malaria: Primates are hosts to various species of Plasmodium parasites that cause malaria.
5. Hepatitis: Primates can be infected with hepatitis viruses, including hepatitis B and C.
6. Respiratory infections: Primates can suffer from respiratory infections caused by bacteria, viruses, or fungi.
7. Gastrointestinal diseases: Primates can develop gastrointestinal disorders due to bacterial, viral, or parasitic infections.
8. Neurological disorders: Primates can suffer from neurological conditions such as encephalitis and meningitis caused by various pathogens.
9. Reproductive diseases: Primates can experience reproductive health issues due to infectious agents or environmental factors.
10. Cancer: Primates, like humans, can develop cancer, which can be caused by genetic predisposition, viral infections, or environmental factors.

Understanding primate diseases is crucial for the conservation of endangered species, managing zoonotic diseases that can spread from animals to humans, and advancing medical research, particularly in the fields of infectious diseases and cancer.

The decidua is a specialized type of tissue that lines the uterus during pregnancy. It forms after the implantation of a fertilized egg (embryo) into the uterine lining, and it plays an important role in supporting the growth and development of the embryo and fetus.

The decidua is composed of several layers, including the decidual capsularis, which surrounds the embryo, and the decidual parietalis, which lines the rest of the uterus. The tissue is rich in blood vessels and contains a variety of immune cells that help to protect the developing fetus from infection.

During pregnancy, the decidua produces various hormones and growth factors that support the growth of the placenta, which provides nutrients and oxygen to the fetus. After the birth of the baby, the decidua is shed along with the placenta in a process called childbirth or parturition.

It's worth noting that abnormalities in the decidua can contribute to pregnancy complications such as preeclampsia, preterm labor, and miscarriage.

Peritoneal diseases refer to a group of conditions that affect the peritoneum, which is the thin, transparent membrane that lines the inner wall of the abdomen and covers the organs within it. The peritoneum has several functions, including providing protection and support to the abdominal organs, producing and absorbing fluids, and serving as a site for the immune system's response to infections and other foreign substances.

Peritoneal diseases can be broadly classified into two categories: infectious and non-infectious. Infectious peritoneal diseases are caused by bacterial, viral, fungal, or parasitic infections that spread to the peritoneum from other parts of the body or through contaminated food, water, or medical devices. Non-infectious peritoneal diseases, on the other hand, are not caused by infections but rather by other factors such as autoimmune disorders, cancer, or chemical irritants.

Some examples of peritoneal diseases include:

1. Peritonitis: Inflammation of the peritoneum due to bacterial or fungal infections, often caused by a ruptured appendix, perforated ulcer, or other abdominal injuries or conditions.
2. Tuberculous peritonitis: A form of peritonitis caused by Mycobacterium tuberculosis, the bacterium that causes tuberculosis (TB).
3. Peritoneal dialysis-associated peritonitis: Infection of the peritoneum in patients undergoing peritoneal dialysis, a type of kidney replacement therapy for patients with end-stage renal disease.
4. Malignant peritoneal mesothelioma: A rare and aggressive form of cancer that affects the mesothelial cells lining the peritoneum, often caused by exposure to asbestos.
5. Systemic lupus erythematosus (SLE): An autoimmune disorder that can cause inflammation and scarring of the peritoneum.
6. Peritoneal carcinomatosis: The spread of cancer cells from other parts of the body to the peritoneum, often seen in patients with advanced ovarian or colorectal cancer.
7. Cirrhotic ascites: Fluid accumulation in the peritoneal cavity due to liver cirrhosis and portal hypertension.
8. Meigs' syndrome: A rare condition characterized by the presence of a benign ovarian tumor, ascites, and pleural effusion.

Ovulation is the medical term for the release of a mature egg from an ovary during a woman's menstrual cycle. The released egg travels through the fallopian tube where it may be fertilized by sperm if sexual intercourse has occurred recently. If the egg is not fertilized, it will break down and leave the body along with the uterine lining during menstruation. Ovulation typically occurs around day 14 of a 28-day menstrual cycle, but the timing can vary widely from woman to woman and even from cycle to cycle in the same woman.

During ovulation, there are several physical changes that may occur in a woman's body, such as an increase in basal body temperature, changes in cervical mucus, and mild cramping or discomfort on one side of the lower abdomen (known as mittelschmerz). These symptoms can be used to help predict ovulation and improve the chances of conception.

It's worth noting that some medical conditions, such as polycystic ovary syndrome (PCOS) or premature ovarian failure, may affect ovulation and make it difficult for a woman to become pregnant. In these cases, medical intervention may be necessary to help promote ovulation and increase the chances of conception.

An Intrauterine Device (IUD) is a long-acting, reversible contraceptive device that is inserted into the uterus to prevent pregnancy. It is a small T-shaped piece of flexible plastic with strings attached to it for removal. There are two types of IUDs available: hormonal and copper. Hormonal IUDs release progestin, which thickens cervical mucus and thins the lining of the uterus, preventing sperm from reaching and fertilizing an egg. Copper IUDs, on the other hand, produce an inflammatory reaction in the uterus that is toxic to sperm and eggs, preventing fertilization.

IUDs are more than 99% effective at preventing pregnancy and can remain in place for several years, depending on the type. They are easily removable by a healthcare provider if a woman wants to become pregnant or choose another form of contraception. IUDs do not protect against sexually transmitted infections (STIs), so it is important to use condoms in addition to an IUD for protection against STIs.

In summary, Intrauterine Devices are small, T-shaped plastic devices that are inserted into the uterus to prevent pregnancy. They come in two types: hormonal and copper, both of which work by preventing fertilization. IUDs are highly effective, long-acting, and reversible forms of contraception.

Anovulation is a medical condition in which there is a failure to ovulate, or release a mature egg from the ovaries, during a menstrual cycle. This can occur due to various reasons such as hormonal imbalances, polycystic ovary syndrome (PCOS), premature ovarian failure, excessive exercise, stress, low body weight, or certain medications. Anovulation is common in women with irregular menstrual cycles and can cause infertility if left untreated. In some cases, anovulation may be treated with medication to stimulate ovulation.

An ovary is a part of the female reproductive system in which ova or eggs are produced through the process of oogenesis. They are a pair of solid, almond-shaped structures located one on each side of the uterus within the pelvic cavity. Each ovary measures about 3 to 5 centimeters in length and weighs around 14 grams.

The ovaries have two main functions: endocrine (hormonal) function and reproductive function. They produce and release eggs (ovulation) responsible for potential fertilization and development of an embryo/fetus during pregnancy. Additionally, they are essential in the production of female sex hormones, primarily estrogen and progesterone, which regulate menstrual cycles, sexual development, and reproduction.

During each menstrual cycle, a mature egg is released from one of the ovaries into the fallopian tube, where it may be fertilized by sperm. If not fertilized, the egg, along with the uterine lining, will be shed, leading to menstruation.

The vagina is the canal that joins the cervix (the lower part of the uterus) to the outside of the body. It also is known as the birth canal because babies pass through it during childbirth. The vagina is where sexual intercourse occurs and where menstrual blood exits the body. It has a flexible wall that can expand and retract. During sexual arousal, the vaginal walls swell with blood to become more elastic in order to accommodate penetration.

It's important to note that sometimes people use the term "vagina" to refer to the entire female genital area, including the external structures like the labia and clitoris. But technically, these are considered part of the vulva, not the vagina.

Follicle-Stimulating Hormone (FSH) is a glycoprotein hormone secreted by the anterior pituitary gland. In humans, FSH plays a crucial role in the reproductive system. Specifically, in females, it stimulates the growth of ovarian follicles in the ovary and the production of estrogen. In males, FSH promotes the formation of sperm within the testes' seminiferous tubules. The human FSH is a heterodimer, consisting of two noncovalently associated subunits: α (alpha) and β (beta). The alpha subunit is common to several pituitary hormones, including thyroid-stimulating hormone (TSH), luteinizing hormone (LH), and human chorionic gonadotropin (hCG). In contrast, the beta subunit is unique to FSH and determines its biological specificity. The regulation of FSH secretion is primarily controlled by the hypothalamic-pituitary axis, involving complex feedback mechanisms with gonadal steroid hormones and inhibins.

Follicle-Stimulating Hormone (FSH) is a glycoprotein hormone secreted and released by the anterior pituitary gland. In females, it promotes the growth and development of ovarian follicles in the ovary, which ultimately leads to the maturation and release of an egg (ovulation). In males, FSH stimulates the testes to produce sperm. It works in conjunction with luteinizing hormone (LH) to regulate reproductive processes. The secretion of FSH is controlled by the hypothalamic-pituitary-gonadal axis and its release is influenced by the levels of gonadotropin-releasing hormone (GnRH), estrogen, inhibin, and androgens.

Stromal cells, also known as stromal/stroma cells, are a type of cell found in various tissues and organs throughout the body. They are often referred to as the "connective tissue" or "supporting framework" of an organ because they play a crucial role in maintaining the structure and function of the tissue. Stromal cells include fibroblasts, adipocytes (fat cells), and various types of progenitor/stem cells. They produce and maintain the extracellular matrix, which is the non-cellular component of tissues that provides structural support and biochemical cues for other cells. Stromal cells also interact with immune cells and participate in the regulation of the immune response. In some contexts, "stromal cells" can also refer to cells found in the microenvironment of tumors, which can influence cancer growth and progression.

Matrix metalloproteinases (MMPs) are a group of enzymes responsible for the degradation and remodeling of the extracellular matrix, the structural framework of most tissues in the body. These enzymes play crucial roles in various physiological processes such as tissue repair, wound healing, and embryonic development. They also participate in pathological conditions like tumor invasion, metastasis, and inflammatory diseases by breaking down the components of the extracellular matrix, including collagens, elastins, proteoglycans, and gelatins. MMPs are zinc-dependent endopeptidases that require activation from their proenzyme form to become fully functional. Their activity is tightly regulated at various levels, including gene expression, protein synthesis, and enzyme inhibition by tissue inhibitors of metalloproteinases (TIMPs). Dysregulation of MMPs has been implicated in several diseases, making them potential therapeutic targets for various clinical interventions.

Menopause is a natural biological process that typically occurs in women in their mid-40s to mid-50s. It marks the end of menstrual cycles and fertility, defined as the absence of menstruation for 12 consecutive months. This transition period can last several years and is often accompanied by various physical and emotional symptoms such as hot flashes, night sweats, mood changes, sleep disturbances, and vaginal dryness. The hormonal fluctuations during this time, particularly the decrease in estrogen levels, contribute to these symptoms. It's essential to monitor and manage these symptoms to maintain overall health and well-being during this phase of life.

Medroxyprogesterone Acetate (MPA) is a synthetic form of the natural hormone progesterone, which is often used in various medical applications. It is a white to off-white crystalline powder, slightly soluble in water, and freely soluble in alcohol, chloroform, and methanol.

Medically, MPA is used as a prescription medication for several indications, including:

1. Contraception: As an oral contraceptive or injectable solution, it can prevent ovulation, thicken cervical mucus to make it harder for sperm to reach the egg, and alter the lining of the uterus to make it less likely for a fertilized egg to implant.
2. Hormone replacement therapy (HRT): In postmenopausal women, MPA can help manage symptoms associated with decreased estrogen levels, such as hot flashes and vaginal dryness. It may also help prevent bone loss (osteoporosis).
3. Endometrial hyperplasia: MPA can be used to treat endometrial hyperplasia, a condition where the lining of the uterus becomes too thick, which could potentially lead to cancer if left untreated. By opposing the effects of estrogen, MPA helps regulate the growth of the endometrium.
4. Gynecological disorders: MPA can be used to treat various gynecological disorders, such as irregular menstrual cycles, amenorrhea (absence of menstruation), and dysfunctional uterine bleeding.
5. Cancer treatment: In some cases, MPA may be used in conjunction with other medications to treat certain types of breast or endometrial cancer.

As with any medication, Medroxyprogesterone Acetate can have side effects and potential risks. It is essential to consult a healthcare professional for proper evaluation, dosage, and monitoring when considering this medication.

Gonadal steroid hormones, also known as gonadal sex steroids, are hormones that are produced and released by the gonads (i.e., ovaries in women and testes in men). These hormones play a critical role in the development and maintenance of secondary sexual characteristics, reproductive function, and overall health.

The three main classes of gonadal steroid hormones are:

1. Androgens: These are male sex hormones that are primarily produced by the testes but also produced in smaller amounts by the ovaries and adrenal glands. The most well-known androgen is testosterone, which plays a key role in the development of male secondary sexual characteristics such as facial hair, deepening of the voice, and increased muscle mass.
2. Estrogens: These are female sex hormones that are primarily produced by the ovaries but also produced in smaller amounts by the adrenal glands. The most well-known estrogen is estradiol, which plays a key role in the development of female secondary sexual characteristics such as breast development and the menstrual cycle.
3. Progestogens: These are hormones that are produced by the ovaries during the second half of the menstrual cycle and play a key role in preparing the uterus for pregnancy. The most well-known progestogen is progesterone, which also plays a role in maintaining pregnancy and regulating the menstrual cycle.

Gonadal steroid hormones can have significant effects on various physiological processes, including bone density, cognitive function, mood, and sexual behavior. Disorders of gonadal steroid hormone production or action can lead to a range of health problems, including infertility, osteoporosis, and sexual dysfunction.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

Weight loss is a reduction in body weight attributed to loss of fluid, fat, muscle, or bone mass. It can be intentional through dieting and exercise or unintentional due to illness or disease. Unintentional weight loss is often a cause for concern and should be evaluated by a healthcare professional to determine the underlying cause and develop an appropriate treatment plan. Rapid or significant weight loss can also have serious health consequences, so it's important to approach any weight loss plan in a healthy and sustainable way.

An encyclopedia is a comprehensive reference work containing articles on various topics, usually arranged in alphabetical order. In the context of medicine, a medical encyclopedia is a collection of articles that provide information about a wide range of medical topics, including diseases and conditions, treatments, tests, procedures, and anatomy and physiology. Medical encyclopedias may be published in print or electronic formats and are often used as a starting point for researching medical topics. They can provide reliable and accurate information on medical subjects, making them useful resources for healthcare professionals, students, and patients alike. Some well-known examples of medical encyclopedias include the Merck Manual and the Stedman's Medical Dictionary.

Obesity is a complex disease characterized by an excess accumulation of body fat to the extent that it negatively impacts health. It's typically defined using Body Mass Index (BMI), a measure calculated from a person's weight and height. A BMI of 30 or higher is indicative of obesity. However, it's important to note that while BMI can be a useful tool for identifying obesity in populations, it does not directly measure body fat and may not accurately reflect health status in individuals. Other factors such as waist circumference, blood pressure, cholesterol levels, and blood sugar levels should also be considered when assessing health risks associated with weight.

Body weight is the measure of the force exerted on a scale or balance by an object's mass, most commonly expressed in units such as pounds (lb) or kilograms (kg). In the context of medical definitions, body weight typically refers to an individual's total weight, which includes their skeletal muscle, fat, organs, and bodily fluids.

Healthcare professionals often use body weight as a basic indicator of overall health status, as it can provide insights into various aspects of a person's health, such as nutritional status, metabolic function, and risk factors for certain diseases. For example, being significantly underweight or overweight can increase the risk of developing conditions like malnutrition, diabetes, heart disease, and certain types of cancer.

It is important to note that body weight alone may not provide a complete picture of an individual's health, as it does not account for factors such as muscle mass, bone density, or body composition. Therefore, healthcare professionals often use additional measures, such as body mass index (BMI), waist circumference, and blood tests, to assess overall health status more comprehensively.

Weight gain is defined as an increase in body weight over time, which can be attributed to various factors such as an increase in muscle mass, fat mass, or total body water. It is typically measured in terms of pounds or kilograms and can be intentional or unintentional. Unintentional weight gain may be a cause for concern if it's significant or accompanied by other symptoms, as it could indicate an underlying medical condition such as hypothyroidism, diabetes, or heart disease.

It is important to note that while body mass index (BMI) can be used as a general guideline for weight status, it does not differentiate between muscle mass and fat mass. Therefore, an increase in muscle mass through activities like strength training could result in a higher BMI, but this may not necessarily be indicative of increased health risks associated with excess body fat.

Body Mass Index (BMI) is a measure used to assess whether a person has a healthy weight for their height. It's calculated by dividing a person's weight in kilograms by the square of their height in meters. Here is the medical definition:

Body Mass Index (BMI) = weight(kg) / [height(m)]^2

According to the World Health Organization, BMI categories are defined as follows:

* Less than 18.5: Underweight
* 18.5-24.9: Normal or healthy weight
* 25.0-29.9: Overweight
* 30.0 and above: Obese

It is important to note that while BMI can be a useful tool for identifying weight issues in populations, it does have limitations when applied to individuals. For example, it may not accurately reflect body fat distribution or muscle mass, which can affect health risks associated with excess weight. Therefore, BMI should be used as one of several factors when evaluating an individual's health status and risk for chronic diseases.

Connective tissue diseases (CTDs) are a group of disorders that involve the abnormal production and accumulation of abnormal connective tissues in various parts of the body. Connective tissues are the structural materials that support and bind other tissues and organs together. They include tendons, ligaments, cartilage, fat, and the material that fills the spaces between cells, called the extracellular matrix.

Connective tissue diseases can affect many different systems in the body, including the skin, joints, muscles, lungs, kidneys, gastrointestinal tract, and blood vessels. Some CTDs are autoimmune disorders, meaning that the immune system mistakenly attacks healthy connective tissues. Others may be caused by genetic mutations or environmental factors.

Some examples of connective tissue diseases include:

* Systemic lupus erythematosus (SLE)
* Rheumatoid arthritis (RA)
* Scleroderma
* Dermatomyositis/Polymyositis
* Mixed Connective Tissue Disease (MCTD)
* Sjogren's syndrome
* Ehlers-Danlos syndrome
* Marfan syndrome
* Osteogenesis imperfecta

The specific symptoms and treatment of connective tissue diseases vary depending on the type and severity of the condition. Treatment may include medications to reduce inflammation, suppress the immune system, or manage pain. In some cases, surgery may be necessary to repair or replace damaged tissues or organs.

Koutras, D. A. (1997-06-17). "Disturbances of menstruation in thyroid disease". Annals of the New York Academy of Sciences. 816 ... "Disturbances of menstruation in hypothyroidism". Clinical Endocrinology. 50 (5): 655-659. doi:10.1046/j.1365-2265.1999.00719.x ... The lack of menstruation usually begins shortly after beginning the medication and can take up to a year to resume after ... Primary amenorrhoea is the absence of menstruation in a woman by the age of 16. Females who have not reached menarche at 14 and ...
Koutras DA (June 1997). "Disturbances of menstruation in thyroid disease". Annals of the New York Academy of Sciences. 816 (1 ...
... renal capacity and depletion leading to water and electrolyte disturbances; thermoregulation; and menstruation. Malnutrition ...
... and changes in menstruation. Menstruation disturbances experienced in women commonly manifests as amenorrhea or oligomenorrhea ... Unlike women, men do not experience reliable indicators of elevated prolactin such as menstruation to prompt immediate medical ... "Physiology of the Endometrium and Regulation of Menstruation". Physiological Reviews. 100 (3): 1149-1179. doi:10.1152/physrev. ...
ISBN 978-1-544-39360-5. Prior JC (2020). "The menstrual cycle: its biology in the context of silent ovulatory disturbances". In ... The word menstruation is etymologically related to moon. The terms menstruation and menses are derived from the Latin mensis ' ... Quotations related to Menstruation at Wikiquote Media related to Menstruation at Wikimedia Commons (CS1 maint: DOI inactive as ... Menstruation in mammals occurs in some close evolutionary relatives such as chimpanzees. Niddah (Jewish laws of menstruation) ...
Menstruation can have a notable impact on mental health, with some individuals experiencing mood disturbances and ... The period before menstruation, known as the premenstrual phase, is often linked to emotional distress. Conditions related to ... Menstruation is linked to a range of psychopathological symptoms, such as lower self-esteem, increased anxiety, dysphoria, and ... Menstruation involves hormonal fluctuations and physiological changes in the body, which can affect a person's mood and ...
Physical symptoms may include sleep disturbance, anorexia (lack of appetite), loss of menstruation for women, headaches, ...
... psychological disturbances and poor sleep pattern. Females may present with low levels of estrogen and abnormal menstruation. ...
Expansion of the tumor may cause headaches and visual disturbances. In addition, compression of the surrounding normal ... pituitary tissue can alter production of other hormones, leading to changes in menstruation and breast discharge in women and ...
Gynecologic disturbances, also generally causing chronic blood loss From menstruation, mostly among young women or older women ... Disturbance of proliferation and differentiation of stem cells Pure red cell aplasia Aplastic anemia affects all kinds of blood ... Chronic anemia may result in behavioral disturbances in children as a direct result of impaired neurological development in ... Anemia of kidney failure due to insufficient production of the hormone erythropoietin Anemia of endocrine disease Disturbance ...
80% of those on dialysis have sleep disturbances. Sleep apnea can occur 10 times as often in uremic patients than in the ... Ordinarily, these episodes appear 2 weeks before menstruation. A few studies have attested that some hormones as prolactin and ... The behavioral disturbances can be composed of hyperphagia, irritability, or sexual disinhibition. The cognitive disorders ... Moldofsky H, Scarisbrick P, England R, Smythe H (1975). "Musculosketal symptoms and non-REM sleep disturbance in patients with ...
If menstruation occurs less often or not at all, some form of progestogen replacement is recommended. A 2017 review concluded ... infertility and cycle disturbance. [...] If the serum testosterone concentration is >4.8 nmol/1, other causes of ... If fertility is not the primary aim, then menstruation can usually be regulated with a contraceptive pill. The purpose of ... p. 141) Polycystic ovaries: PCOS is a complicated disorder characterized by high androgen levels, irregular menstruation, and/ ...
Menstruation in Islam Postpartum period Menstruation cycle Intimate parts in Islam Women as imams Culture and menstruation ... In Islam, the Istihadha (Arabic: اِسْتِحَاضَةٌ; flowing blood) represents a disturbance of the menstrual cycle of the woman ... Since her fast is valid, the mustahadha will make up the days of her menstruation if she knows that, either by the time of the ... A woman must abstain from fasting only at the time of her period and the occurrence of her monthly menstruation cycle, and if ...
Around half of post-menopausal women experience sleep disturbances, and generally sleep disturbance is about twice as common in ... Hormone shifts such as those that precede menstruation and those during menopause Life events such as fear, stress, anxiety, ... However, dependence on opioids can lead to long-term sleep disturbances. Insomnia affects people of all age groups but people ... Actigraphy is indicated as a method to characterize circadian patterns or sleep disturbances in individuals with insomnia, ... ...
... testicular torsion Metabolic disturbance uremia, diabetic ketoacidosis, porphyria, C1-esterase inhibitor deficiency, adrenal ... menstruation, Mittelschmerz Tumors: endometriosis, fibroids, ovarian cyst, ovarian cancer Pregnancy: ruptured ectopic pregnancy ...
... and reduces sleep disturbances and hypertension. Iyengar yoga is effective at least in the short term for both neck pain and ... menstruation; neck injury; pregnancy; and shoulder injury. The practice of asanas has sometimes been advised against during ...
Severe symptoms can begin and worsen until the onset of menstruation, with many not feeling relief until a few days after ... Daily charting helps to distinguish when mood disturbances are experienced and allows PMDD to be more easily distinguished from ... Two approaches to dosing have been studied: continuous dosing (daily) and luteal dosing (14 days before menstruation and ... Many women of reproductive age experience discomfort or mild mood changes prior to menstruation. However, 5-8% experience ...
Criterion B) Disturbance in the way a person's weight or body shape is experienced or a lack of recognition about the risks of ... causing menstruation to change drastically or to stop all together Dry hair and skin, as well as hair thinning Fear of even the ... The DSM-5 describes this perceptual symptom as "disturbance in the way in which one's body weight or shape is experienced". In ... March 2021). "Body perception treatment, a possible way to treat body image disturbance in eating disorders: a case-control ...
Most women taking moderate doses of spironolactone develop amenorrhea, and normal menstruation usually returns within two ... Regardless of their mechanism, the menstrual disturbances associated with spironolactone can usually be controlled well by ... In females spironolactone can induce menstrual disturbances, breast enlargement and breast tenderness.78 In men spironolactone ... These irregularities include metrorrhagia (intermenstrual bleeding), amenorrhea (absence of menstruation), and breakthrough ...
Menstruation (also called menstrual bleeding, menses or a period) is the first and most evident phase of the uterine cycle and ... Prior JC (2020). "The menstrual cycle: its biology in the context of silent ovulatory disturbances". In Ussher JM, Chrisler JC ... Measured from the first day of one menstruation to the first day of the next, the length of a menstrual cycle varies but has a ... Menstruation occurs on average once a month from menarche to menopause, which corresponds with a woman's fertile years. The ...
Historically, the concept that menstruation did not have beneficial effects, and that menstruation could be controlled was ... However, disturbance of the menstrual cycle is common with the mini-pill; one-third to one-half of women taking it will ... The English language version, title, "Is Menstruation Obsolete: How suppressing menstruation can help women who suffer from ... Management of menstruation may be a challenge for those with developmental delay or intellectual disability, and menstrual ...
Areas of research include menstruation and ovulation, bone health, premenopausal breast cancer, polycystic ovary syndrome (PCOS ... CeMCOR is the only centre in the world that focuses on ovulation and the causes and consequences of ovulation disturbances. ...
Combined with mood disturbances, idealization and devaluation can undermine relationships with family, friends, and co-workers ... Symptoms begin during the luteal phase of the menstrual cycle, and end during menstruation. Symptoms may include marked mood ... Chapman & Gratz 2007, p. 88 Selby EA (October 2013). "Chronic sleep disturbances and borderline personality disorder symptoms ... Identity disturbance, manifested in markedly and persistently unstable self-image or sense of self; A tendency to act rashly in ...
... adhesions restricted to only the cervix or lower uterus may block menstruation. Pain during menstruation and ovulation is ... AS can be the cause of menstrual disturbances, infertility, and placental abnormalities. Although the first case of ... which is shed during menstruation and an underlying basal layer (adjacent to the myometrium), which is necessary for ...
Menopause is the permanent cessation of menstruation resulting from loss of ovarian follicular activity, defined as beginning ... In various placebo-controlled studies, improvements in vasomotor symptoms, emotional response, sleep disturbances, physical ... diminished feminine fat distribution and accelerated skin aging Sleep disturbances and joint pain The most common of these are ...
While menstruation is heavily associated with human females, and they have the most pronounced menstruation, it is also typical ... Since the vaginal flora gives protection against disease, a disturbance of this balance may lead to infection and abnormal ... the middle of or a little prior to menstruation, or during pregnancy. Menstruation (also known as a "period" or "monthly") is ... "Menstruation and the menstrual cycle fact sheet". Office of Women's Health. December 23, 2014. Archived from the original on ...
The disturbance of the naturally occurring vaginal microbiota associated with bacterial vaginosis increases the risk of PID. N ... or irregular menstruation. Untreated PID can result in long-term complications including infertility, ectopic pregnancy, ... or irregular menstruation may be noted. Other complications include endometritis, salpingitis, tubo-ovarian abscess, pelvic ...
... to relieve various stomach ailments or to treat women with pregnancy or menstruation-related problems. The fruits are sweet and ... and can become an important component of ground cover after low and moderate-intensity disturbance, thereby reducing soil water ...
Vaginitis an inflammation of the vagina, such as caused by infection, hormone disturbance and irritation/allergy. List of ... Most vaginal discharges occur due to normal bodily functions, such as menstruation or sexual arousal (vaginal lubrication). ...
KLS should also be distinguished from very rare cases of menstruation-caused hypersomnia. Lithium is the only drug that appears ... Outside of episodes, there is no disturbance in patients' sleep patterns and they are generally asymptomatic. Patients do not ...
Menstruation, Retrograde; Polymenorrhea; Menstruation Disorders. On-line free medical diagnosis assistant. Ranked list of ... Menstruation Disturbances (Hypomenorrhea; Menstruation, Retrograde; Polymenorrhea; Menstruation Disorders). Variations of ... Ranked list of diseases related to "Menstruation Disturbances"Drugs, active principles and "Menstruation Disturbances"Medicinal ...
Menstruation (or period) happens monthly. As the uterus sheds its lining, vaginal bleeding follows. Menstrual blood is made of ... ClinicalTrials.gov: Menstruation Disturbances (National Institutes of Health) Journal Articles References and abstracts from ... About Menstruation (Eunice Kennedy Shriver National Institute of Child Health and Human Development) Also in Spanish ... Menstruation, or period, is normal vaginal bleeding that occurs as part of a womans monthly cycle. Every month, your body ...
Koutras, D. A. (1997-06-17). "Disturbances of menstruation in thyroid disease". Annals of the New York Academy of Sciences. 816 ... "Disturbances of menstruation in hypothyroidism". Clinical Endocrinology. 50 (5): 655-659. doi:10.1046/j.1365-2265.1999.00719.x ... The lack of menstruation usually begins shortly after beginning the medication and can take up to a year to resume after ... Primary amenorrhoea is the absence of menstruation in a woman by the age of 16. Females who have not reached menarche at 14 and ...
Menstruation Disturbances / etiology * Ovary / physiopathology * Pregnancy * Sexual Maturation * Testis / physiopathology * ...
Disturbances of menstruation in hypothyroidism. Clin Endocrinol (Oxf). 1999 May. 50 (5):655-9. [QxMD MEDLINE Link]. ... Persistent menstrual disturbances might lead to chronic iron loss in up to 30% of patients with iron deficiency anemia. ... Women with hypothyroidism most often have normal menstrual cycles (about 70%). The most common disturbance is cycles of greater ... Research studies point to a local disturbance in hemostasis and vasoconstriction. Endometrial tissue has altered ...
Menstruation Disturbances / drug therapy * Phytotherapy* * Plant Extracts / pharmacology * Plant Extracts / therapeutic use* ...
Menstruation is a process that induces a series of hormonal and structural changes in the female reproductive system to foster ... Association between menstrual disturbances and caffeine intake 3. Please cite this article in press as: Bin Mahmoud AZ, et al ... Association between menstrual disturbances and habitual use of caffeine. *September 2014. *Journal of Taibah University Medical ... Please cite this article in press as: Bin Mahmoud AZ, et al., Association between menstrual disturbances and habitual use of ...
menstruation.. Malnutrition can lead to vitamin and other deficiencies and to inactivity, which in turn may pre-dispose to ... renal capacity and depletion leading to water and electrolyte disturbances;. *thermoregulation; and ...
Condition(s) targeted: Dysmenorrhea; Menstruation Disturbances; Menstruation Disorders. Intervention: ORTHO EVRA, the ... Menstruation: choosing whether...and when. Contraception. 2000 Dec;62(6):277-84. Review.. Last updated: August 27, 2013 ... The studys instruments will focus on eliciting information on the personal and economic costs of menstruation such as ... Braunstein JB, Hausfeld J, Hausfeld J, London A. Economics of reducing menstruation with trimonthly-cycle oral contraceptive ...
GIT disturbance (OR 2.8, 95% CI 2.2-3.6), and dysmenorrhea (OR 2.6, 95% CI 1.6-4.3). Insomnia has been shown to be ... Therefore, the disturbance of these hormones can lead to both poor sleep and menstrual irregularities [16]. Besides, physical ... Knox B, Azurah A, Grover S (2015) Quality of life and menstruation in adolescents. Curr Opin Obstet Gynecol 27:309-314 ... compared the sleeping disturbances between women with and without premenstrual syndrome and concluded that those with ...
diseases of female genital organs (disordered menstruation, sterility, chronic inflammation). * disturbances in the vegetative ...
We used 29 of 31 symptom types (Figure 3); we excluded erectile dysfunction and abnormal menstruation because those symptoms ... We observed time trends of increasing aORs for diminished ability to concentrate, brain fog, sleep disturbance, tinnitus, and ... We asked about abnormal menstruation but did not include more granular HPO terminology, such as amenorrhea, irregular ... Arthralgia or joint swelling, rhinorrhea, diarrhea, abnormal menstruation, skin rash, eye symptoms, and constipation had aORs , ...
At the time, people hadnt really started talking about menstrual cycle disturbances after COVID-19 vaccination yet. ... Tags:COVID-19immune responseinfectious diseaseinflammationmenstrual cyclemenstruationNewsvaccineswomens health ... The menstruation and vaccination conundrum. During the menstrual cycle, the brain releases hormones over the course of about 28 ... The research so far suggests that there is in fact a connection between the COVID-19 vaccines and menstruation but that it is ...
... secretion thereby often altering reproductive processes inducing significant disturbances leading abnormally timed menstruation ... Your diet plays an important role in maintaining hormonal balance within your body which affects how regularly menstruation ... Ensuring regulary influenced exercise routine holds humongous advantages such as decreasing occurrence of mood disturbances ... maybe she has planned a beach vacation or needs some personal time without any disturbance. ...
Loss or disturbance of menstruation. • Fainting or dizziness. • Sensitivity to the cold. • Bloating, constipation, or the ... Sleep disturbances. Behavioural warning signs. • Repetitive dieting behaviour such as counting calories, skipping meals, ...
... pregnancy and the menopause mean that many women experience periods of insomnia and sleep disturbance. ... Sleep disturbance in women is affected by natural events in most womens lives. Menstruation, pregnancy and the menopause cause ... Aerobic exercise has been shown to be one of the best ways of reducing symptoms and combating mood disturbance. Exercise should ... Sleep may be disrupted for up to two weeks before menstruation. Other symptoms such as tenderness in the breasts, bloating, ...
Symptoms include dysmenorrhoea, heavy menstrual bleeding and premenstrual mood disturbances with reported prevalence of 45%-90 ... Menstruation and suggested implications for schools and workplaces. From the respondent who had been calling in sick due to ... Conclusions Menstruation-related symptoms cause a great deal of lost productivity, and presenteeism is a bigger contributor to ... Quality of life and menstruation in adolescents. Curr Opin Obstet Gynecol2015;27:309-14.doi:10.1097/GCO.0000000000000199. ...
... causing further disturbances in the environment. ... In summary, sustainable menstruation is both eco-friendly and ... Adopting Sustainable Menstruation Practices. Sustainable menstruation can be achieved through the utilization of products such ... Embracing Sustainable Menstruation: A Positive Impact. Aside from the environmental benefits, using sustainable menstruation ... Menstrual cups to period underwear: Heres how to practice sustainable menstruation. By NCVC Staff , Published on Oct 11, 2023 ...
Menstruation will occur 2-3 days after stopping the treatment. Menstruation can be deferred for a few days or weeks or several ... Side effects include mood disturbance, acne and headache [46]. The Mirena does not increase the risk of VTE, it does not ... To defer menstruation, either NET (5 mg b.d.) or MPA (10 mg t.d.s.) is started 5 days before the anticipated event and taken ... Medical indications for this would include the need to avoid menstruation at the time of a complex planned surgical procedure ...
I have gained a lot a weight lately which I have been told can cause disturbances in your menstrual cycle. I have had a pap ... Q: Continuous menstruation. I write to you about my daughter, who is now at the age of 17. She started her menstruation period ... Q: Unusual menstruation. I am 26 yrs old experiencing a rather unusual menstruation. I have hypothyroidism and am taking ... A:Menstruations are 28 days apart with normal variations of 7 days. Duration of flow is 4 days with normal variations of about ...
Common sources of migraines can include stress, sleep disturbance, dehydration, and-for women-hormonal changes due to ... menstruation. Certain foods can also precipitate migraine, such as caffeine, alcohol, and foods containing aspartame or ...
Menstruation Disturbances 2 0 Posterior Tibial Tendon Dysfunction 2 0 Social Perception 2 0 ...
A second rationale is that hormonal methods reduce menstrual disturbances when initiated during menstruation, and the IUD is ... Menstruation requirements: a significant barrier to contraceptive access in developing countries. Studies in Family Planning, ...
A scientific-looking report shows menstruation problems after COVID vaccination, showing a significant increase in menstrual ... disturbance for the Pfizer and Moderna jabs.. And a "not significant" increase of more than 20% for Astazeneca.. .. ...
This can affect ovarian function and lead to cyclical disturbances such as irregular menstruation or amenorrhea (absence of ... menstruation).. * Polycystic ovarian syndrome (PCOS): Neurosis may exacerbate the symptoms of polycystic ovarian syndrome. ...
The antispasmodic feature of this herb can also relieve the cramping associated with menstruation. Resveratrol (Polygonum ... sleep disturbances, and emotional symptoms. ...
Some patients may get a transitory prodromal non-itchy rash, headache, visual disturbance or anxiety ... menstruation, pregnancy, oestrogen) ...
... and behavioral disturbances related to female reproductive stages, including menstruation, pregnancy and the postpartum period ...
Sleep Disturbances During Menstruation: C... November 30, 2023. Sleep disturbances are common during menstruation. From ... Sleep Disturbances During Menstruation: C... November 30, 2023. Sleep disturbances are common during menstruation. From ... Teen Period Panties: A Revolution For Teenage Girls And First Menstruation The... ...

No FAQ available that match "menstruation disturbances"